emtricitabine 200 MG / rilpivirine 25 MG / tenofovir alafenamide 25 MG Oral Tablet [Odefsey]
RxNorm concept 1741739, branded drug (sbd). Prescribable name: ODEFSEY 200 MG / 25 MG/ 25 MG Oral Tablet.
- RxCUI
- 1741739
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1741739 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Odefsey (emtricitabine 200 MG / rilpivirine 25 MG (as rilpivirine HCl 27.5 MG) / tenofovir alafenamide 25 MG (as tenofovir alafenamide fumarate 28 MG)) Oral Tablet
Related concepts
- emtricitabine 200 MG (SCDC, consists of)
- rilpivirine 25 MG (SCDC, consists of)
- tenofovir alafenamide 25 MG (SCDC, consists of)
- emtricitabine 200 MG / rilpivirine 25 MG / tenofovir alafenamide 25 MG [Odefsey] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Odefsey (BN, has ingredient)
- emtricitabine 200 MG / rilpivirine 25 MG / tenofovir alafenamide 25 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 50090234000
- 61958210101
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1741739 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1741739 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1741739. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.